Medical Principles and Practice

Original Paper

Free Access

Involvement of Opioid, Adenosine and 5-HT3 Receptors in Antinociceptive Effects of an Ayurvedic Polyherbal Formulation

Chandrasekar S.B.a · Divakar K.a · Pawar A.T.a · Goli D.a · Harisha R.b · Bhanumathy M.c · Sushma G.c · Shivaprasad H.N.c

Author affiliations

aDepartment of Pharmacology, Acharya BM Reddy College of Pharmacy, Soldevanahalli, bMilind Institute of Pharmacy, Kurubarahalli, and cNatural Remedies Pvt. Ltd., Bangalore, India

Corresponding Author

S.B. Chandrasekar, M. Pharm.

Department of Pharmacology, Acharya BM Reddy College of Pharmacy

Soldevanahalli, Hesaraghatta Main Road, Chikabhanavara Post

Bangalore 90, Karnataka (India)

Tel. +91 99 8638 7768, E-Mail sbchandrasekar@gmail.com

Related Articles for ""

Med Princ Pract 2011;20:66–70

Abstract

Objective: The present study was undertaken to evaluate the antinociceptive effects of an ayurvedic polyherbal formulation in rats and mice employing the tail immersion test and acetic acid-induced writhing test, respectively. Materials and Methods: With the tail immersion method, rats received two different doses (270 and 405 mg/kg BW, p.o.) of a formulation, pethidine (5.4 mg/kg BW, p.o.) as a reference standard and the combination of the higher dose of the formulation with naloxone (2 mg/kg, i.p.), an opioid receptor antagonist, and caffeine (16 mg/kg, i.p.), used as an adenosine receptor antagonist. In the acetic acid-induced writhing test, mice received two different doses (390 and 585 mg/kg, BW, p.o.) of formulation, diclofenac sodium (15 mg/kg, BW, p.o.) as a reference standard and the combination of the higher dose of the polyherbal formulation with ondansetron (0.5 mg/kg, i.p.), a serotonin receptor antagonist. Results: The polyherbal formulation (405 mg/kg) exhibited a significant (p < 0.01) antinociceptive effect using the tail immersion method. In the acetic acid-induced writhing test, the formulation showed significant (p < 0.01) dose-dependent activity. The antinociceptive effect of the polyherbal formulation apparently involved an opiate-like mechanism, since its antinociceptive action was attenuated by naloxone pretreatment. In addition, antinociceptive activity was attenuated by caffeine and reversed by ondansetron pretreatment. Conclusion: Our data suggest that the polyherbal formulation possessed centrally and peripherally mediated antinociceptive properties. The activity could be mediated through opioid, adenosine, and serotonin receptors and via inhibition of cyclo-oxygenase- and/or lipoxygenase-dependent pathways.

© 2010 S. Karger AG, Basel




Related Articles:


References

  1. Ojewole JA: Analgesic, anti-inflammatory and hypoglycaemic effects of Rhus chirindensis (Baker F.) [Anacardiaceae] stem-bark aqueous extract in mice and rats. J Ethnopharmacol 2007;113:338–345.
  2. Badar VA, Thawani VR, Wakode PT, Shrivastava MP, Gharpure KJ: Efficacy of Tinospora cordifolia in allergic rhinitis. J Ethnopharmacol 2005;96:445–459.
  3. Bafna PA, Balarman R: Anti-ulcer and anti-oxidant activity of Pepticare, a herbomineral formulation. Phytomedicine 2005;12:264–270.
  4. Rasool M, Varalakshmi P: Suppressive effect of Withania somnifera root powder on experimental gouty arthritis: an in vivo and in vitro study. Chem Biol Interact 2006;164:174–180.
  5. Rasool M, Sabina EP: Antiinflammatory effect of the Indian Ayurvedic herbal formulation Triphala on adjuvant induced arthritis in mice. Phytother Res 2007;21:889–894.
  6. Kumar MS, Kirubanandan S, Sripriya R, Sehgal PK: Triphala incorporated collagen sponge: a smart biomaterial for infected dermal wound healing. J Surg Res 2010;158:162–170.
  7. Bhandage A: Evaluation of antinociceptive activity of roots of Glycyrrhiza glabra Linn. J Pharm Res 2009;2:803–807.
  8. Almeida RN, Navarro DS, Barbosa-Filho JM: Plants with central analgesic activity. Phytomedicine 2001;8:310–322.
  9. Bharat Reddy D, Reddy TCM, Jyotsna G, Sharan S, Priya N, Lakshmipathi V, Pallu R: Chebulagic acid, a COX-LOX dual inhibitors isolated from the fruits of Terminalia chebla Retz., induces apoptosis in COLO cell line. J Ethnopharmacol 2009;124:506–512.
  10. Vedhanayki G, Shastri GV, Kuruvilla A: Analgesic activity of Piperlongum root. Indian J Exp Biol 2003;41:649–651.
    External Resources
  11. Kokate CK: Practical Pharmacognosy. Pune, Nirali Prakashan, 2000, pp 106–111.
  12. Gosh MN: Fundamentals of Experimental Pharmacology, ed 3. Kolkata, Scientific Book Agency, 1984, p 192.
  13. Mahesh SK, Naik SR, Kohli RK: Anti-inflammatory, antiarthritic and analgesic activity of a herbal formulation (DRF/AY/4012). Indian J Exp Biol 2007;45:278–284.
    External Resources
  14. Adair RSS, Vinicius MG, Gerson LO, Daiane T, Ana FP, Amaro N, Humberto MS: Mechanisms involved in the antinociception caused by agmatine in mice. Neuropharmacology2005;48:1021–1034.
  15. Shrinivas KK, Ipe N: Inhibition of morphine tolerance and dependence by Withania somnifera in mice. J Ethnopharmacol 1997;57:213–217.
  16. Yashpal K, Henry JL: Adenosine receptor link in an adrenal opioid induced antinociception in the rat tail-flick test. Neurosci Lett 1992;138:253–256.
  17. Deraedt R, Jouquey S, Delevallee F, Flahaut M: Release of prostaglandins E and F in an algogenic reaction and its inhibition. Eur J Pharmacol 1980;61:17–24.
  18. Ku EC, Lee W, Kothari HV, Scholer DW: Effect of diclofenac sodium on the arachidonic acid cascade. Am J Med 1986;80:18–23.
  19. Kintz P, Godelar B, Mangin P, Lugnier A, Chaumont A: Simultaneous determination of pethidine (meperidine), phenoperidine, and norpethidine (normeperidine), their common metabolite, by gas chromatography with selective nitrogen detection. Forensic Sci Int 1989;43:267–273.
  20. Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Protoghese PS, Haman M: Classification of opioid receptors. Pharmcol Rev 1996;48:567–592.
  21. Grumbach L: The production of analgesic activity in man by animal testing; in Knighton RS, Dumke PR (eds): Pain. Boston, Little Brown, 1966, pp 163–182.
  22. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE: Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999;51:83–133.
  23. Sawynok J, Yaksh YL: Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev 1993;45:43–85.
  24. Bittar M, de Sousa MM, Yunes R, Lento RA, Delle Monache F, Cechinel Filho V: Antinociceptive activity of 13,118-binaringenin, a biflavonoid present in plants of the guttiferae. Planta Med 2000;66:84–86.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: October 21, 2009
Accepted: April 19, 2010
Published online: December 13, 2010
Issue release date: December 2010

Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 2

ISSN: 1011-7571 (Print)
eISSN: 1423-0151 (Online)

For additional information: https://www.karger.com/MPP


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP